Journal of virology

Long COVID with brain-related symptoms is linked to changes in coordinated immune responses to COVID-19 and lower immune response to Epstein-Barr virus up to 12 months after infection

Updated

Abstract

Approximately 400 million people worldwide are estimated to be affected by long COVID.

  • No significant differences in immune responses to SARS-CoV-2, Epstein-Barr virus (EBV), or human cytomegalovirus (HCMV) were found between long COVID individuals and recovered participants at 3-6 months post-COVID-19 symptom onset.
  • Altered coordination between T-cell responses and neutralizing antibodies was observed in the long COVID group, unlike in recovered individuals.
  • Diminished levels of EBV-specific antibodies were significantly noted in long COVID participants at 3-6 months post-COVID-19 symptom onset.
  • One long COVID participant exhibited EBV reactivation, as indicated by specific antibody presence.
  • Reports of fatigue at 12 months post-COVID-19 symptom onset were associated with reduced EBV neutralizing capacity at 3-6 months.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free